About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Maxwell Biosciences Marks Scientist Appreciation Day With Renewed Call to Recognize Scientists

By: Newsfile

Company holiday celebrates scientific impact and invites underrecognized researchers to connect

Austin, Texas--(Newsfile Corp. - August 18, 2025) - Maxwell Biosciences, a global health technology company pioneering a new category of immune-inspired small molecules called Claromers™, today celebrates Scientist Appreciation Day, an official company holiday that honors the essential contributions of scientists. The observance is a call to give scientists greater visibility and broader recognition of their work at a time when scientific research faces growing challenges in visibility, funding and public support.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/9658/262232_141c765f342278ba_001.jpg

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9658/262232_141c765f342278ba_001full.jpg

Scientist Appreciation Day is celebrated annually by Maxwell's team. This year, the company is sharing its message more broadly to recognize the impact of people behind global scientific progress and to invite scientists working on complex or overlooked problems to reach out and connect. Moving forward, Maxwell's observance of Scientist Appreciation Day will take place on the third Friday in August.

"At Maxwell, we believe scientists are heroes— almost like wizards working to improve the human experience while exploring the inner cosmos," said Scotch McClure, founder, CEO and chairman of Maxwell Biosciences. "Their work forms the backbone of human advancement, yet many receive little recognition. If you're an underfunded scientist with real vision— we see you. If you're a brilliant scientist with incredible discoveries awaiting the world's attention, reach out. We're inviting you."

In an era when researchers are expected to do more with less— often behind the scenes— Maxwell is making its appreciation public. The company invites researchers across fields such as biotechnology, medical sciences, materials science, immunology and AI-driven drug discovery to contribute to a shared vision to create health for the world, safely and affordably.

About Maxwell Biosciences
Maxwell Biosciences is an AI-driven global health technology company pioneering a new category of immune-inspired small molecules called Claromers. Designed to mimic the body's natural defenses, Claromers destroy pathogenic bacteria, viruses, fungi and biofilms— without harming healthy cells or the microbiome.

Originally developed for critical infectious diseases, Maxwell's technology is now entering commercial deployment across cosmetics, personal care, medical coatings and livestock health. Claromers require no refrigeration and are highly stable in even the harshest environments.

Backed by a decade of research, a robust patent portfolio and leadership with deep expertise in science, military, AI and global health, Maxwell has active partnerships with the US military and governments worldwide. FDA clinical trials are planned for 2026. Non-pharmaceutical commercialization begins in 2025, with pilot access with select partners already underway.

Maxwell's AI-first platform enables rapid innovation against the rising threat of resistant pathogens, offering scalable, shelf-stable and microbiome-resilient solutions for a healthier planet.

To learn more about Maxwell Biosciences, visit MaxwellBiosciences.com, or follow us on X and LinkedIn.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/262232

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.